| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.02 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.03 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.089 | 0.03 |